Drug profile · INN
mitotane
LYSODREN
mitotane (LYSODREN) is a cytochrome p450 11b1 inhibitor. Associated with S.A.. Route of administration: oral. Current US regulatory status: approved.
Drug details — mitotane
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- ORAL
- Patents
- 10
- Programs
- 1
- Data quality
- 0.89
Quick answer
mitotane (LYSODREN) is a cytochrome p450 11b1 inhibitor. Associated with S.A.. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cytochrome P450 11B1 inhibitor
Primary target: Cholesterol side-chain cleavage enzyme, mitochondrial
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12263227
Optimized mRNA encoding CAS9 for use in LNPs
granted -
US 12227763
Methods and compositions for treating cancer
granted -
US 12188060
Messenger RNA encoding Cas9 for use in genome-editing systems
granted -
US 12016932
Gene editing for hemophilia A with improved factor VIII expression
granted -
US 11833225
Methods and compositions for efficient gene deletion
granted -
US 11827877
Compositions and methods for genomic editing by insertion of donor polynucleotides
granted -
US 11649438
Methods and compositions for treating cancer
granted -
US 11529427
Gene editing for hemophilia A with improved factor VIII expression
granted -
US 11332760
Compositions and methods for genomic editing by insertion of donor polynucleotides
granted -
US 11254912
Methods and compositions for treating cancer
granted
Frequently asked questions
What is mitotane?
mitotane (LYSODREN) is a cytochrome p450 11b1 inhibitor. Associated with S.A.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for mitotane?
LYSODREN is a marketed brand name for mitotane. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mitotane?
mitotane has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.